U-Blot® Research Grade DurvalumabCat. No. WA2704$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade DurvalumabCat. No. WA2704
U-Blot® Research Grade DupilumabCat. No. WA2703
U-Blot® Research Grade dulpatatugCat. No. WA2702
U-Blot® Research Grade DuligotuzumabCat. No. WA2701
U-Blot® Research Grade DulaglutideCat. No. WA2700
U-Blot® Research Grade DrozitumabCat. No. WA2699
U-Blot® Research Grade drotokibartCat. No. WA2698
U-Blot® Research Grade DresbuxelimabCat. No. WA2697
U-Blot® Research Grade DovanvetmabCat. No. WA2696
U-Blot® Research Grade DostarlimabCat. No. WA2695
U-Blot® Research Grade DonzakimigCat. No. WA2694
U-Blot® Research Grade DonitabartCat. No. WA2693